Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus
about
Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort studyControlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing.Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemicEradication of methicillin-resistant Staphylococcus aureus with an antiseptic soap and nasal mupirocin among colonized patients--an open uncontrolled clinical trialUse of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care unitsGuidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspectiveHospital epidemiology and infection control in acute-care settings.Transmission dynamics of methicillin-resistant Staphylococcus aureus in a medical intensive care unit.Identification and Discrimination of Methicillin Resistant Staphylococcus aureus Strains Isolated from Burn Wound Sites Using PCR and Authentication with MALDI-TOF-MS.The role of Staphylococcus aureus carriage in the pathogenesis of bloodstream infectionMolecular analysis of methicillin-resistant Staphylococcus aureus as a causative agent of bronchopulmonary infection: relation to colonization in the upper respiratory tract.Low concentrations of mupirocin in the pharynx following intranasal application may contribute to mupirocin resistance in methicillin-resistant Staphylococcus aureus.Successful control of methicillin-resistant Staphylococcus aureus in endemic neonatal intensive care units--a 7-year campaign.Phenotypic and genotypic mupirocin resistance among Staphylococci causing prosthetic joint infection.Higher prevalence of pharyngeal than nasal Staphylococcus aureus carriage in pediatric intensive care unitsSuccessful treatment for carriage of methicillin-resistant Staphylococcus aureus and importance of follow-upStaphylococcus aureus nasal colonization and subsequent infection in intensive care unit patients: does methicillin resistance matter?Reduced costs for Staphylococcus aureus carriers treated prophylactically with mupirocin and chlorhexidine in cardiothoracic and orthopaedic surgery.Does the nose know? An update on MRSA decolonization strategies.Rapid detection of methicillin-resistant Staphylococcus aureus directly from sterile or nonsterile clinical samples by a new molecular assay.Effectiveness of hospital-wide methicillin-resistant Staphylococcus aureus (MRSA) infection control policies differs by ward specialty.Effect of maternal skin-to-skin contact on decolonization of Methicillin-Oxacillin-Resistant Staphylococcus in neonatal intensive care units: a randomized controlled trial.MRSA screening in the vascular day-case population.Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial.Methicillin-resistant Staphylococcus aureus in community-acquired skin infectionsCombined topical and oral antimicrobial therapy for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) colonization in hospitalized patients.Risk Factors of Methicillin-Resistant Staphylococcus aureus Infection and Correlation With Nasal Colonization Based on Molecular Genotyping in Medical Intensive Care Units: A Prospective Observational StudyThe economic effect of screening orthopedic surgery patients preoperatively for methicillin-resistant Staphylococcus aureus.Efficacy of the decolonization of methicillin-resistant Staphylococcus aureus carriers in clinical practiceThe economic value of screening haemodialysis patients for methicillin-resistant Staphylococcus aureus in the USA.Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: A perspective for Canadian health care practitioners.Impact of Host Heterogeneity on the Efficacy of Interventions to Reduce Staphylococcus aureus Carriage.Integrated MRSA-Management (IMM) with prolonged decolonization treatment after hospital discharge is effective: a single centre, non-randomised open-label trial.Strain-relatedness of methicillin-resistant Staphylococcus aureus isolates recovered from patients with repeated infection.A double-blind, randomized, controlled trial of topical polysporin triple compound versus topical mupirocin for the eradication of colonization with methicillin-resistant Staphylococcus aureus in a complex continuing care population.Recurrent furunculosis - challenges and management: a review.Community-Associated Methicillin-Resistant Staphylococcus aureus in the Pediatric Population.Microbiological effect of mupirocin and chlorhexidine for Staphylococcus aureus decolonization in community and nursing home based adults.The management of infection and colonization due to methicillin-resistant Staphylococcus aureus: A CIDS/CAMM position paper.A decline in mupirocin resistance in methicillin-resistant Staphylococcus aureus accompanied administrative control of prescriptions.
P2860
Q21195056-29063018-5094-4FE7-916F-0CF2E2C6ED20Q24547449-C61BF812-4D5C-45DD-9D79-8BDEDF019B31Q24614464-66D16BE6-30F1-4CFB-A8B5-41A58E0686B4Q24792687-A059A5C8-A2AD-4364-A4FA-6E0D6A5BAF3CQ24811715-086ABEB1-AEB3-4D47-966C-4F136AC6FBEDQ28388806-F745E2D9-58BE-4F28-823C-EEAE3E85DF9DQ30429049-9385F019-5D65-4580-B5E3-58987C419F15Q30524359-35184D69-0734-4795-B0A0-4FD252490BBBQ31136313-7E5F8B32-EAFB-4216-AC95-DFDE73521DD1Q33905845-E245C9ED-FD16-46A5-A0B1-4FEC9B30E77DQ33970086-EAD466FF-6A0C-4DBD-9384-5F4697AC09EBQ33973800-6A3D03AB-884F-427E-AC35-973E855B3552Q33999091-9EE2DC7C-5568-4673-89D8-834A50AD67C4Q34041943-7C904A61-A0D2-4872-9E10-6F4DE253C631Q34046494-8F6EB757-DAFB-47D6-8953-CA1C352C59D9Q34108643-072BC5E6-6409-464E-A2BB-9DF1B162289CQ34133374-2A1B63DB-CBF0-49C8-B171-83E81C7EB0B5Q34391293-866F9820-FEA2-4621-83AE-D521DBA66A4AQ34649978-2E8E48C8-A247-470A-92E4-E5623D4D981EQ34746780-568EAA23-D535-4D0A-9B35-11B761B1F210Q35067961-21BC929F-2937-4022-B4B0-FC52A9B757B8Q35218987-69A02560-2FF3-4864-B56C-9D3764146892Q35801148-10AA8E78-4909-494B-AA7D-92D1F3DD3787Q35870407-CF68EBA5-3368-40B0-8897-8500BE948BC4Q36009334-6D9F561E-434F-415A-BF3F-015FC7BF7401Q36170598-641B8CB6-B789-4EC1-8E4D-A65B6352BA2BQ36196653-DAA07957-7178-452A-BB28-B2B71BAB5806Q36351234-6B624208-FE8F-46E1-BE3A-D7063DD84B70Q36384059-1D40A57A-DF1B-4525-B6FB-2515F2349791Q36557836-053FC346-BE5E-4799-B225-BDD09842415AQ36563779-551837DF-2F46-45CF-B22F-5CF54C72B16BQ36598451-3624478B-2783-4FC9-AA63-461ABD7796CCQ37006691-0634C3B3-BA28-49AC-BB88-6CF61C03D984Q37297030-324BC210-DA3F-44AF-BA5E-DD59EA4D9597Q37405328-B8983911-FFB4-453A-90AF-B21C3B48F869Q37602969-DC96F00E-4D3D-4A58-A394-9BE3B3B3B2CFQ38051319-56612534-C69D-4236-9140-2C61A2994828Q40326612-C5F643A8-DC4B-4C92-830A-3195D947E204Q40667218-0B31DF6C-6E0C-43AB-BF53-6A5166CFF878Q40937956-10D2676C-DE9F-4445-9DD1-FFA83CB0C724
P2860
Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Randomized, placebo-controlled ...... esistant Staphylococcus aureus
@ast
Randomized, placebo-controlled ...... esistant Staphylococcus aureus
@en
Randomized, placebo-controlled ...... esistant Staphylococcus aureus
@nl
type
label
Randomized, placebo-controlled ...... esistant Staphylococcus aureus
@ast
Randomized, placebo-controlled ...... esistant Staphylococcus aureus
@en
Randomized, placebo-controlled ...... esistant Staphylococcus aureus
@nl
prefLabel
Randomized, placebo-controlled ...... esistant Staphylococcus aureus
@ast
Randomized, placebo-controlled ...... esistant Staphylococcus aureus
@en
Randomized, placebo-controlled ...... esistant Staphylococcus aureus
@nl
P2093
P2860
P3181
P356
P1476
Randomized, placebo-controlled ...... esistant Staphylococcus aureus
@en
P2093
Auckenthaler R
Harbarth S
Herrault P
Liassine N
P2860
P304
P3181
P356
10.1128/AAC.43.6.1412
P407
P577
1999-06-01T00:00:00Z